| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |